Award Winning Biotech Company Offers New Program For Travelers Who Have to Take Medication But Are Afraid to Drink the Water
FLAVORx, the world-renowned biotech company that has flavored more than 45 million prescriptions in nearly 30,000 pharmacies worldwide, offers a new solution to aide travelers afraid to drink questionable water in foreign locations.
(PRWEB) July 27, 2005 -- FLAVORx, the Maryland-based biotech company that for
the previous decade has helped physicians, pharmacists and veterinarians turn
bitter-tasting medications into tasty, flavored liquids, offers a suggestion to
the traveling public as the busy summer travel season proceeds.
"This
summer, folks will be traveling at record levels," states Kenny Kramm, FLAVORx
President and CEO. "Travelers taking pills or capsules, who plan on visiting or
passing through areas where water may be suspect, may want to consult with their
pharmacists and request that their prescriptions, or even some of those
hard-to-take vitamins, be compounded into easily swallowed liquids. This will
eliminate the risk of picking up any water-borne ailments in non-potable
water."
"All too often, especially in hot weather, pills swallowed 'dry'
will transit the esophagus slower than was pharmaceutically intended, causing
irritation, even ulceration, as the pills and capsules start to dissolve before
they reach the stomach."
With more than 27,000 pharmacies and 2,000
veterinary hospitals using the proprietary FLAVORX formulary to compound
good-tasting, readily-accepted medications, patients (and their traveling pets)
will have no problem finding a pharmacy capable of turning their prescriptions,
over-the-counter medications and vitamins into flavorful liquids that do not
have to be washed down with water.
Patients can find the pharmacy or
veterinarian nearest to them by going to the FLAVORx website (www.flavorx.com) or by calling
1-800-884-5771. With this concern behind them, travelers can do what they were
meant to do on vacation: enjoy themselves.
# # #
Source : http://www.prweb.com/releases/2005/7/prweb265889.htm